论文部分内容阅读
目的：对于慢阻肺急性加重期患者来说，运用糖皮质激素联合特布他林治疗方法，探究其临床疗效。方法：2010年5月至2015年5月期间，我院接收慢阻肺急性加重期患者共计89例，按照住院时间顺序依次编号，前44例患者接受单纯特布他林治疗，为对照组，另45例患者接受糖皮质激素联合特布他林治疗，即试验组，比较两组患者入院前、出院后血气指标数值、治疗后血气指标数值的变化。结果：两组患者经过系统治疗后，临床症状基本得到改善，对照组患者治疗后的PaO2、PaCO2指标明显低于试验组，上述差异显著，具有统计学意义（P＜0.05）。结论：对于慢阻肺急性加重期患者应用糖皮质激素联合特布他治疗的临床疗效效果更佳，有较高的痊愈概率。“,”Objective For COPD, to investigate the clinical effect of the treatment combining glucocorticoid with terbutaline.Methods Selected 89 cases of COPD treated in our hospital from May 2010 to May 2015.The former 44 patients received terbutaline treatment named as the control group, the other 45 cases received glucocorticoid therapy combining terbutaline named as test group. Compared blood gas changing before & after admission and thus changing after treatment.Result The two groups’ clinical symptoms was improved,PaO2 and PaCO2 in the control group were significantly lower than the test group(P<0.05).Conclusion The clinical effect of glucocorticoid therapy combined with terbutaline is better, has a higher probability of recovery.